Chain Drug Review - Exforge given FDA approval as treatment for hypertension
Related Results
DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan
> Exforge has received regulatory approval as a treatment for patients with high blood pressure. Manufacturer Novartis AG notes that the product combines in one tablet the two most commonly prescribed hypertension medicines in their categories: Diovan and Norvasc. The new product is expected to be available in the United States in late September pending expiration of patent protection for amlodipine besylate (Norvasc).
COPYRIGHT 2007 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
